Resultados da busca - Lincoff, A Michael
- Mostrando 1 - 20 resultados de 30
- Ir para a próxima página
-
1
Antithrombotic therapy with intracoronary stenting por Steinhubl, Steven R, Lincoff, A Michael
Publicado em 1997Texto -
2
Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis por Hoogwerf, Byron J., Lincoff, A. Michael, Rodriguez, Angel, Chen, Lei, Qu, Yongming
Publicado em 2016Texto -
3
Successful treatment of aortic root dissection complicated with extensive myocardial infarction using the total artificial heart por Attia, Tamer, Robich, Michael, Lincoff, A. Michael, Shishehbor, Mehdi H., Svensson, Lars, Smedira, Nicholas G.
Publicado em 2017Texto -
4
Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis por Riaz, Haris, Khan, Safi U, Rahman, Hammad, Shah, Nishant P, Kaluski, Edo, Lincoff, A Michael, Nissen, Steven E
Publicado em 2018Texto -
5
Drug-Eluting Stents versus Bare-Metal Stents for Treatment of Bare-Metal In-Stent Restenosis por Singh, Inder M., Filby, Steven J., Sakr, Fredy El, Gorodeski, Eiran Z., Lincoff, A. Michael, Ellis, Stephen G., Shishehbor, Mehdi H.
Publicado em 2010Texto -
6
Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phas... por Ruilope, Luis, Hanefeld, Markolf, Lincoff, A Michael, Viberti, Giancarlo, Meyer-Reigner, Sylvie, Mudie, Nadejda, Wieczorek Kirk, Dominika, Malmberg, Klas, Herz, Matthias
Publicado em 2014Texto -
7
Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long‐Term Mortality After Noncardiac Vascular Surgery por Reed, Grant W., Horr, Samuel, Young, Laura, Clevenger, Joshua, Malik, Umair, Ellis, Stephen G., Lincoff, A. Michael, Nissen, Steven E., Menon, Venu
Publicado em 2017Texto -
8
Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial por Mani, Preethi, Puri, Rishi, Schwartz, Gregory G., Nissen, Steven E., Shao, Mingyuan, Kastelein, John J. P., Menon, Venu, Lincoff, A. Michael, Nicholls, Stephen J.
Publicado em 2019Texto -
9
Association of Lowering Low‐Density Lipoprotein Cholesterol With Contemporary Lipid‐Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta‐Analysis por Khan, Safi U., Rahman, Hammad, Okunrintemi, Victor, Riaz, Haris, Khan, Muhammad Shahzeb, Sattur, Sudhakar, Kaluski, Edo, Lincoff, A. Michael, Martin, Seth S., Blaha, Michael J.
Publicado em 2019Texto -
10
Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial Infarction por Nair, Raunak, Johnson, Michael, Kravitz, Kathleen, Huded, Chetan, Rajeswaran, Jeevanantham, Anabila, Moses, Blackstone, Eugene, Menon, Venu, Lincoff, A. Michael, Kapadia, Samir, Khot, Umesh N.
Publicado em 2021Texto -
11
Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes por Kumbhani, Dharam J, Wells, Brian J, Lincoff, A Michael, Jain, Anil, Arrigain, Susana, Yu, Changhong, Goormastic, Marlene, Ellis, Stephen G, Blackstone, Eugene, Kattan, Michael W
Publicado em 2013Texto -
12
Comparison of Clinical Trial Outcome Patterns in Patients Following Acute Coronary Syndromes and in Patients With Chronic Stable Atherosclerosis por Mahaffey, Kenneth W., Wojdyla, Daniel M., Pieper, Karen S., Tricoci, Pierluigi, Alexander, John H., Lincoff, A. Michael, Brennan, Danielle M., Bhatt, Deepak L., Wallentin, Lars, Harrington, Robert A.
Publicado em 2014Texto -
13
Smoking, Clopidogrel, and Mortality in Patients with Established Cardiovascular Disease por Berger, Jeffrey S., Bhatt, Deepak L., Steinhubl, Steven R., Shao, Mingyuan, Steg, P. Gabriel, Montalescot, Gilles, Hacke, Werner, Fox, Keith A., Lincoff, A. Michael, Topol, Eric J., Berger, Peter B.
Publicado em 2009Texto -
14
Primary and Secondary Prevention of Cardiovascular Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinica... por Vandvik, Per Olav, Lincoff, A. Michael, Gore, Joel M., Gutterman, David D., Sonnenberg, Frank A., Alonso-Coello, Pablo, Akl, Elie A., Lansberg, Maarten G., Guyatt, Gordon H., Spencer, Frederick A.
Publicado em 2012Texto -
15
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial por Koomen, Jeroen V., Heerspink, Hiddo J. L., Schrieks, Ilse C., Schwartz, Gregory G., Lincoff, A. Michael, Nicholls, Stephen J., Svensson, Anders, Wedel, Hans, Weichert, Arlette, Grobbee, Diederick E., Stevens, Jasper
Publicado em 2019Texto -
16
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of th... por Puri, Rishi, Nissen, Steven E., Arsenault, Benoit J., St John, Julie, Riesmeyer, Jeffrey S., Ruotolo, Giacomo, McErlean, Ellen, Menon, Venu, Cho, Leslie, Wolski, Kathy, Lincoff, A. Michael, Nicholls, Stephen J.
Publicado em 2020Texto -
17
ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study por Nissen, Steven E., Pillai, Sreekumar G., Nicholls, Stephen J., Wolski, Kathy, Riesmeyer, Jeffrey S., Weerakkody, Govinda J., Foster, Wendra M., McErlean, Ellen, Li, Lin, Bhatnagar, Pallav, Ruotolo, Giacomo, Lincoff, A. Michael
Publicado em 2018Texto -
18
Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High‐Risk Vascular Disease: Insights From the ACCELERATE Trial por Kumar, Anirudh, Patel, Divyang R., Brennan, Danielle M., Wolski, Kathy E., Lincoff, A. Michael, Ruotolo, Giacomo, McErlean, Ellen, Weerakkody, Govinda, Riesmeyer, Jeffrey S., Nicholls, Stephen J., Nissen, Steven E., Menon, Venu
Publicado em 2019Texto -
19
Genome-wide Polygenic Score and Cardiovascular Outcomes with Evacetrapib in Patients with High-risk Vascular Disease: A Nested Case-control Study por Emdin, Connor A., Bhatnagar, Pallav, Wang, Minxian, Pillai, Sreekumar G., Li, Lin, Qian, Hui-Rong, Riesmeyer, Jeffrey S., Lincoff, A. Michael, Nicholls, Stephen J., Nissen, Steven E., Ruotolo, Giacomo, Kathiresan, Sekar, Khera, Amit V.
Publicado em 2020Texto -
20
Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High‐Risk Vascular Disease Treated With Statin Therapy por Menon, Venu, Kumar, Anirudh, Patel, Divyang R., John, Julie St., Wolski, Kathy E., McErlean, Ellen, Riesmeyer, Jeffrey S., Weerakkody, Govinda, Ruotolo, Giacomo, Cremer, Paul C., Nicholls, Stephen J., Lincoff, A. Michael, Nissen, Steven E.
Publicado em 2019Texto